Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
International Journal of Radiation Oncology, Biology, Physics|September 1, 2020
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG CollaborationYolanda D Tseng, Bradford S Hoppe, Katerina Dedeckova, et al.
Journal of Medicinal Chemistry|July 22, 2016
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 InhibitorsErin F DiMauro, Stephen Altmann, Loren M Berry, et al.
Frontiers in Oncology|June 9, 2018
An Update From the Pediatric Proton Consortium RegistryClayton B Hess, Daniel J Indelicato, Arnold C Paulino, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target EngagementIsaac E Marx, Thomas A Dineen, Jessica Able, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood CancerJohn C Breneman, Sarah S Donaldson, Louis Constine, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement"Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2017
The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagementDaniel S La, Emily A Peterson, Christiane Bode, et al.
Journal of Medicinal Chemistry|March 14, 2017
Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic LiabilitiesMatthew M Weiss, Thomas A Dineen, Isaac E Marx, et al.
ACS Chemical Biology|March 16, 2019
Engineering NaV1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance PharmacokineticsJustin K Murray, Bin Wu, Christopher M Tegley, et al.
Pediatric Blood & Cancer|August 11, 2020
Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group reportChia-Ho Hua, Tamara Z Vern-Gross, Clayton B Hess, et al.
Pageof 43